Scholar Rock Holding Corp
SRRK Nasdaq· Biological Products, (No Diagnostic Substances)
Last close · Oct 26, 2026
$41.71
KIRA · Stoqly’s AI analyst, in plain words
- Scholar Rock Holding Corp had $0.0M of revenue in fiscal 2025.
- Scholar Rock Holding Corp lost $378M in fiscal 2025.
- Free cash flow was −$301M in fiscal 2025, — of revenue.
- Scholar Rock Holding Corp has $268M more cash than debt.
Market cap
$5.4B
P/E
—
Revenue
$0.0M
Net income
−$378M
Free cash flow
−$301M
Operating margin
—
Scholar Rock Holding Corp in 30 seconds · fiscal 2025
Does it make a profit?
−$378M
No. It lost money last year.
How healthy are the accounts?
1 / 7
Weak. It passes 1 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Scholar Rock Holding Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 3, 2026
- Legal name
- Scholar Rock Holding Corp
- CIK
- 0001727196
Scholar Rock Holding Corp · SRRK
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $18.8M | $33.2M | — | — | $0.0M |
| Revenue growth | 22.2% | 76.4% | — | — | — |
| Operating margin | −690.5% | −404.8% | — | — | — |
| Net income | −$132M | −$135M | −$166M | −$246M | −$378M |
| Net margin | −700.5% | −405.2% | — | — | — |
| Diluted EPS | −$3.59 | −$2.26 | −$1.99 | −$2.47 | −$3.29 |
| Cash | |||||
| Cash from operations | −$127M | −$133M | −$145M | −$201M | −$300M |
| Capital expenditure | $5.2M | $1.1M | $0.1M | $0.1M | $0.6M |
| Free cash flow | −$132M | −$134M | −$145M | −$201M | −$301M |
| FCF margin | −701.7% | −403.0% | — | — | — |
| Share count change | 19.4% | 62.4% | 39.8% | 19.8% | 14.9% |
| Debt and strength | |||||
| Cash and short-term investments | $253M | $315M | $280M | $437M | $368M |
| Debt incl. finance leases | $53.6M | $51.0M | $52.3M | $50.1M | $99.7M |
| Shareholders' equity | $172M | $260M | $225M | $369M | $245M |
| Current ratio | 4.1x | 9.0x | 8.8x | 9.6x | 6.9x |
| Interest coverage | −61.9x | −28.6x | −26.4x | −36.9x | −55.8x |
| Returns and quality | |||||
| Return on equity | −60.9% | −62.2% | −68.3% | −82.9% | −123.1% |
| Return on tangible equity | −76.6% | −51.7% | −73.6% | −66.8% | −154.0% |
| Piotroski F-score | 2 | 5 | 1 | 4 | 1 |
| Altman Z'' | −1.2 | 1.0 | −2.6 | −0.7 | −9.9 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$19.4M
13 insiders
Of sales under plans
45%
$8.8M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Scholar Rock Holding Corp · SRRK
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $41.71 a share, the company is worth $5.4B.
Source: SEC EDGAR XBRL filings (CIK 0001727196). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.